Daniele Xavier Assad

11PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Aboriginal and Torres Strait Islander nursingModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 06, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520).

Leandro Jonata de Carvalho Oliveira, Daniella Castro Araújo, Júlio Antonio Pereira de Araújo

|Jan 30, 2026
Cost-Effectiveness of the Oncotype DX Breast Recurrence Score Test in the Brazilian Private Health Care Sector.

Ivan Zimmermann, Carlos Alberto da Silva Magliano, Leandro Jonata de Carvalho Oliveira

|Jan 23, 2026
Sexual dysfunction in Brazilian women undergoing adjuvant endocrine therapy for breast cancer: prevalence and associated factors.

Daniele Assad-Suzuki, Danielle Laperche-Santos, Heloisa Resende

|Oct 30, 2025
Employment Status Among Brazilian Women With Estrogen Receptor-Positive Nonmetastatic Breast Cancer.

Daniele Assad-Suzuki, Luciana Castro Garcia Landeiro, Danielle Laperche-Santos

|Oct 22, 2025
Budget Impact of the Oncotype DX Test in Early-Stage Breast Cancer for the Brazilian Private Health Care System.

Carlos Alberto da Silva Magliano, Ivan R Zimmermann, Leandro Jonata de Carvalho Oliveira

|Oct 08, 2025
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor-Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil.

Romualdo Barroso-Sousa, Danielle Laperche-Santos, Heloisa Resende

Pageof 2

Frequent Collaborators

5 joint publications

Andrea Kazumi Shimada

3 joint publications

Leandro Jonata de Carvalho Oliveira

3 joint publications

Romualdo Barroso-Sousa

3 joint publications

Carlos Eduardo Paiva